This module was part of a live event that occurred between March 27-28, 2025. If you attended the live event please do not claim credit for this module.

Faculty

Needs Statement

Kentucky is among the states leading the country in HCV infections. It is critical for professionals to have current knowledge to provide effective treatment and education for patients. According to the CDC, Kentucky is at high risk for a HIV outbreak if introduced into the drug using population. HIV therapy was previously limited due to lack of treatment options, but more therapy options increase choice for patient treatment and challenges for providers. Screening for drug misuse is critical to the prevention of or early intervention in addiction.

Identifying and overcoming barriers to care engagement and continuous ART, therefore, must be an overarching priority of HIV primary care. Ensuring stigma-free, culturally appropriate, and patient-centered care experiences is essential to maximize care engagement, treatment adherence, and viral suppression.

Target Audience

Physicians, physician assistants, advanced practice nurses, nurses, pharmacists, dentists, social workers, health educators and therapists who currently provide or could provide care services to persons living with HIV/AIDS or Hepatitis C.

Objectives

Upon completion of this activity, participants will be able to:
1. Discuss how to order baseline and monitoring laboratory testing for a person with HIV
2. Describe which co-infections are needed to be routinely screened
3. Review which cancer screenings to order
4. Screen for mental health and substance use disorders and in a person with an opioid use disorder, consider approaches to initiating buprenorphine treatment in the setting of fentanyl use
5. Implement recommendations for Hepatitis B, Mpox and Measles immunizations for people with HIV.
6. Prescribe doxyPEP to prevent chlamydia, syphilis and possibly gonorrhea
7. Prescribe statins as primary prevention for atherosclerotic cardiovascular disease for peole with HIV, based on data from REPRIEVE.

Accreditation

In support of improving patient care, University of Kentucky HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CME
This enduring material is designated for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

CPE
This knowledge-based activity will award 1.50 contact hours (0.150 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.

CDE
This online course meets regulatory requirements for 1.50 hours credit as permitted by 201 KAR 8:532 for dentists and 201 KAR 8:562 for dental hygienists.

ASWB ACE
As a Jointly Accredited Organization, UK HealthCare CECentral is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. UK HealthCare CECentral maintains responsibility for this course. Social workers completing this course receive 1.50 clinical continuing education credits.

CNE
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.50 nursing contact hours.

Faculty Disclosure

All planners, faculty, and others in control of educational content are required to disclose all their financial relationships with ineligible companies within the prior 24 months. An ineligible company is defined as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company.

Melanie Thompson, MD, faculty for this event, was chair/IDMC for Excision Biotechnology, but that relationship has ended

All of the relevant financial relationships listed for these individuals have been mitigated. No other speakers, authors, planners or content reviewers have any relevant financial relationship to disclose

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.

Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Acknowledgment

This program is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U1OHA30535 as part of an award totaling $4.2m. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit HRSA.gov.

“Funding for this presentation was made possible by cooperative agreement U1OHA30535 from the Health Resources and Services Administration HIV/AIDS Bureau. The views expressed do not necessarily reflect the official policies of the Department of Health and Human Services nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. Any trade/brand names for products mentioned during this presentation are for training and identification purposes only.”

This content is owned by the AETC, and is protected by copyright laws.  Reproduction or distribution of the content without written permission of the sponsor is prohibited, and may result in legal action.